VKTX

Viking TherapeuticsB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

VKTX vs peer average

71/100

VKTX vs. peer average (B vs. C)

Grade spread

A 1 · B 2 · C 1 · D 5 · F 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

NVAX is the first available peer comparator.

Small‑cap biotech with development‑stage focus; sensitive to trial outcomes and funding risk similar to VKTX.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerNVAXNovavax

VKTX

Viking Therapeutics

NVAX

Novavax

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs NVAX

VKTX / NVAX

Grade Position

Above peers

VKTX vs. peer average (B vs. C)

71/100

Momentum

VKTX

Value

NVAX

Sentiment

VKTX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs VKTX

NVAX

40/100

CRSP

80/100

Even

ALXO

20/100

CELC

Celcuity Inc Common

40/100

EWTX

Edgewise Therapeutics Inc Common

60/100

NVAX is the first peer returned for this comparison set.